XmAb20717 in Advanced Biliary Tract Cancers

Clinical trial NCT05297903 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05297903
Sponsor: Abramson Cancer Center at Penn Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Cancer

Start date: 2022-04-11
Primary completion: 2026-12-02
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.